Advertisement

Advertisement

2019 Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS)

CNS Cancers
Immunotherapy

By Caroline Helwick  / June 25, 2019  / 2019 Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS)

Update on Early-Stage Studies of Novel Treatments in Glioblastoma

Outcomes are typically grim for patients with recurrent glioblastoma multiforme. At the 2019 Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS), three early-stage st...

CNS Cancers

By Caroline Helwick  / May 25, 2019  / 2019 Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS)

Targeted Brachytherapy May Improve Outcomes in Recurrent Brain Tumors

For recurrent, previously irradiated brain tumors, innovative treatment with surgically targeted brachytherapy yielded good local control and overall survival, as compared to historic controls, neuros...

Advertisement

Advertisement




Apr
25
Today In Oncology
FDA Approves Lu-177 Dotatate for Pediatric Patients With GEP-NETs
AI Model May Help Predict Treatment Responses Select Most Effective Cancer Therapies in Patients With Cancer
In-Hospital Mortality Among Patients With COVID-19 Infection, With or Without Cancer
Imaging Drug to Assist in Detection of Cancerous Tissue Following Lumpectomy Approved
Potential Protective Effects of Aspirin Against Colorectal Cancer
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Designed by Harborside